Quest diagnostics reports second quarter 2023 financial results; updates guidance for full year 2023

Second quarter revenues of $2.34 billion, down 4.7% from 2022 second quarter reported diluted earnings per share ("eps") of $2.05, up 4.6% from 2022; and adjusted diluted eps of $2.30, down 2.5% from 2022 second quarter base business revenues of $2.30 billion, up 9.5% from 2022 full year 2023 revenues now expected to be between $9.12 billion and $9.22 billion; reported diluted eps now expected to be between $7.52 and $7.92; and adjusted diluted eps expected to be between $8.50 and $8.90 secaucus, n.j. , july 26, 2023 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended june 30, 2023.
DGX Ratings Summary
DGX Quant Ranking